Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sohan, Dey"'
Autor:
Lone Hvitfeldt Poulsen, Bryce A. Kerlin, Giancarlo Castaman, Angelo Claudio Molinari, Marzia Menegatti, Diane Nugent, Sohan Dey, May‐Lill Garly, Manuel Carcao
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 2, Pp n/a-n/a (2022)
Abstract Background Regular factor XIII (FXIII) prophylaxis is standard treatment for congenital FXIII A‐subunit deficiency (FXIII‐A CD). Recombinant factor XIII‐A2 (rFXIII‐A2) was extensively evaluated in the mentor trials. Objective To asse
Externí odkaz:
https://doaj.org/article/5a6d8df7f0b441e8a7dd4b247b17f799
Autor:
Roger E. G. Schutgens, Annie Borel Derlon, Sohan Dey, Barbara Faganel Kotnik, Olga Katsarou, Carmen Escuriola Ettingshausen, Irina Matytsina, Paula F. Ypma, Rudolf Schwarz
Publikováno v:
Haemophilia. 28:46-54
Introduction Turoctocog alfa (NovoEight® ) is a B-domain-truncated recombinant factor VIII (FVIII) approved for patients with haemophilia A. Aim To investigate the long-term safety and efficacy of turoctocog alfa in routine clinical practice. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2234e03b4a541b4524ce3793e697b973
https://doi.org/10.1111/hae.14454
https://doi.org/10.1111/hae.14454
Autor:
Christoph Male, Christoph Königs, Sohan Dey, Tadashi Matsushita, Anders Holm Millner, Marek Zak, Guy Young, Gili Kenet
Publikováno v:
Blood advances.
N8-GP (turoctocog alfa pegol) is a recombinant, glycoPEGylated, extended half-life, factor VIII replacement product. Here, we examined the immunogenicity, safety, and efficacy of N8-GP in previously untreated patients (PUPs). pathfinder6 is an ongoin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::566b6a7376dd18d050fdcb974c3b37ce
https://pubmed.ncbi.nlm.nih.gov/35858373
https://pubmed.ncbi.nlm.nih.gov/35858373
Autor:
Lone Hvitfeldt, Poulsen, Bryce A, Kerlin, Giancarlo, Castaman, Angelo Claudio, Molinari, Marzia, Menegatti, Diane, Nugent, Sohan, Dey, May-Lill, Garly, Manuel, Carcao
Publikováno v:
Research and practice in thrombosis and haemostasis. 6(2)
Regular factor XIII (FXIII) prophylaxis is standard treatment for congenital FXIII A-subunit deficiency (FXIII-A CD). Recombinant factor XIII-ATo assess real-world safety and treatment effectiveness of rFXIII-Amentor 6 was a noninterventional, postau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8ca013747953076f2c32caa8fbf312a5
https://pubmed.ncbi.nlm.nih.gov/35243202
https://pubmed.ncbi.nlm.nih.gov/35243202
Autor:
Gopinath Halder, Shraboni Mukherjee, Madhumanti Mondal, Sohan Dey, Sumit H. Dhawane, Soumya Banerjee, Debaprasad Dutta
Publikováno v:
Sustainable Energy Technologies and Assessments. 18:16-33
Madhuca indica (Mahua flowers) abundantly available in tropical region of India was used to produce bioethanol using Saccharomyces cerevisiae in batch fermentation process. The experiments were investigated at three different initial substrate concen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::402cc1845938de51e1b6b1bfd1eb69ce
https://doi.org/10.1016/j.seta.2016.09.004
https://doi.org/10.1016/j.seta.2016.09.004